City of Hope raises $4.3M+ with music executive and entrepreneur Lyor Cohen

Young women are now diagnosed with cancer at twice the rate of young men
The face of cancer is changing at a time when research is plagued by existential threats

For more than a year before her stage 4 lung cancer was found, 35-year-old Alisa Secaida, a never-smoker and a physically active Southern Californian, had been experiencing a persistent cough and, increasingly, fatigue.

June 06, 2025

Vol.51 No.22

By Claire Marie Porter

Reimagining cancer care for a new generation of patients

The landscape of cancer is shifting beneath our feet, and we must adapt our clinical practice accordingly.

June 06, 2025

Vol.51 No.22

By Hope S. Rugo

Clinical Trials & Tribulations

Bridging the gaps in cancer care for Hispanics: Striving for equity and fairness in scientific advancements

Our Hispanic community is a vibrant and essential part of the American tapestry, contributing richly to the country’s society, culture, and economy. Yet, when it comes to healthcare, this community grapples with significant disparities, especially in cancer care.

Clairity becomes the first FDA-authorized AI platform for breast cancer prediction

Clairity Inc. received FDA De Novo authorization for CLAIRITY BREAST, a novel, image-based prognostic platform designed to predict five-year breast cancer risk from a routine screening mammogram. With this authorization, Clairity is planning to launch among leading health systems through 2025—propelling a new era of precision medicine in breast cancer.

June 06, 2025

Vol.51 No.22

Harnessing big data and AI to combat colorectal cancer

In the rapidly evolving field of oncology, the integration of big data and artificial intelligence is revolutionizing our approach to cancer research and treatment. The future of precision oncology requires integrating computational approaches with clinical practice.

May 23, 2025

Vol.51 No.20

By Enrique Velazquez Villarreal

City of Hope research showcases innovation at 2025 AACR annual meeting

City of Hope researchers at AACR.City of Hope presented more than 74 sessions at this year’s American Association for Cancer Research Annual Meeting in Chicago, highlighting breakthroughs in diagnostics, treatment options and AI-powered precision medicine.

May 16, 2025

Vol.51 No.19

By City of Hope

City of Hope raises $4.3M+ with music executive and entrepreneur Lyor Cohen

YOU MAY BE INTERESTED IN

Young women are now diagnosed with cancer at twice the rate of young men
The face of cancer is changing at a time when research is plagued by existential threats

Reimagining cancer care for a new generation of patients

Bridging the gaps in cancer care for Hispanics: Striving for equity and fairness in scientific advancements

Clairity becomes the first FDA-authorized AI platform for breast cancer prediction

Harnessing big data and AI to combat colorectal cancer

City of Hope research showcases innovation at 2025 AACR annual meeting

Renew today!

Subscriber content

Never miss an issue!

Login

City of Hope raises $4.3M+ with music executive and entrepreneur Lyor Cohen

YOU MAY BE INTERESTED IN

Young women are now diagnosed with cancer at twice the rate of young menThe face of cancer is changing at a time when research is plagued by existential threats

Reimagining cancer care for a new generation of patients

Bridging the gaps in cancer care for Hispanics: Striving for equity and fairness in scientific advancements

Clairity becomes the first FDA-authorized AI platform for breast cancer prediction

Harnessing big data and AI to combat colorectal cancer

City of Hope research showcases innovation at 2025 AACR annual meeting

Never miss an issue!

Login

Young women are now diagnosed with cancer at twice the rate of young men
The face of cancer is changing at a time when research is plagued by existential threats